VHCP Management, LLC 3
3 · ARCA biopharma, Inc. · Filed Jun 17, 2015
Insider Transaction Report
Form 3
Holdings
- 10,789,324(indirect: By funds)
Common Stock
- (indirect: By funds)
Warrants (right to buy)
Exercise: $0.87From: 2015-12-13Exp: 2022-06-16→ Common Stock (4,315,730 underlying)
Footnotes (3)
- [F1]Consists of: 2,736,388 shares held directly by Venrock Healthcare Capital Partners, L.P. ("VHCP"); 5,373,623 shares held directly by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"); 500,409 shares held directly by VHCP Co-Investment Holdings, LLC ("Co-Invest"); and 2,178,904 shares held directly by VHCP Co-Investment Holdings II, LLC ("Co-Invest II").
- [F2]Consists of: 1,094,555 warrants held directly by VHCP; 2,149,449 warrants held directly by VHCP II; 200,164 warrants held directly by Co-Invest; and 871,562 warrants held directly by Co-Invest II.
- [F3]VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of Co-Invest II and may be deemed to beneficially own these shares. Drs. Anders D. Hove and Bong Y. Koh are the managing members of VHCP Management and VHCP Management II and may be deemed to beneficially own these shares. Drs. Hove and Koh, VHCP Management and VHCP Management II expressly disclaim beneficial ownership over these shares and warrants except to the extent of their indirect pecuniary interests therein.